AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services proposal to require federal minimum staffing levels in nursing homes.

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ list of the first 10 drugs to be negotiated for lower prices by Medicare.

List prices for the 25 brand-name drugs with the highest total Medicare Part D spending in 2021 have increased by an average of 226%—or more than tripled—since they first entered the market, a new report from AARP’s Public Policy Institute shows.

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ final implementation guidance of the Medicare Drug Price Negotiation Program.

AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees’ reports released today.

AARP CEO Jo Ann Jenkins issued the following statement in response to President Biden’s State of the Union speech this evening

AARP CEO Jo Ann Jenkins issued the following statement on the importance of protecting Social Security and Medicare

AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond issued the following statement on the Senate passage of the bipartisan 2023 omnibus bill. Earlier this month, AARP sent a letter to Congressional Leadership urging them to include important priorities for those age 50+ in any year-end legislative package.

The Centers for Medicare & Medicaid Services (CMS) released the 2023 premiums and deductibles for the Medicare Part B programs earlier today. Medicare Part B premiums will decrease by $5.20 to $164.90 next year, and deductibles will decrease $7 to $226. AARP had called for CMS to lower Part B premiums following a decline in the price and coverage of Aduhelm, which accounted for half of the premium increase in 2022.

AARP issued a statement from Jo Ann Jenkins, AARP Chief Executive Officer, after President Biden signed the Inflation Reduction Act of 2022.